|Articles|April 1, 2016

Redefining Easy

The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, offers a broad range of products that span from research and development to production. Visit booth #2841 to learn how our new product innovations will help you simplify your manufacturing processes, allowing you to advance your molecules to market faster and more cost effectively.

MilliporeSigma
INTERPHEX Booth #2841

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Redefining Easy

Newsletter

Trending on BioPharm International

New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline

Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

Implementing Automation and Flexible Design for Allogeneic Manufacturing

Emerging siRNA Platform Offers New Metabolic Disorder Therapies